Detalhe da pesquisa
1.
Differential Diagnosis of Suspected Chronic Obstructive Pulmonary Disease Exacerbations in the Acute Care Setting: Best Practice.
Am J Respir Crit Care Med
; 207(9): 1134-1144, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36701677
2.
Development of a tool to detect small airways dysfunction in asthma clinical practice.
Eur Respir J
; 61(3)2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36517179
3.
Chronic obstructive pulmonary disease exacerbation fundamentals: Diagnosis, treatment, prevention and disease impact.
Respirology
; 26(6): 532-551, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893708
4.
COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors.
Int J Mol Sci
; 22(17)2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34502194
5.
Risk and Prevention of Cardiovacular Events after Exacerbations of Respiratory Symptoms in Patients with COPD.
Am J Respir Crit Care Med
; 209(8): 901-902, 2024 Apr 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319130
6.
Asthma progression and mortality: the role of inhaled corticosteroids.
Eur Respir J
; 54(1)2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31048346
7.
Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.
Respiration
; 97(3): 223-233, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30205380
8.
Determinants of Response to Roflumilast in Severe Chronic Obstructive Pulmonary Disease. Pooled Analysis of Two Randomized Trials.
Am J Respir Crit Care Med
; 198(10): 1268-1278, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29763572
9.
Inhaled corticosteroids in COPD: friend or foe?
Eur Respir J
; 52(6)2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190269
10.
Reply to Bhatt and to Ramakrishnan et al.
Am J Respir Crit Care Med
; 205(9): 1126-1127, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35196478
11.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.
Am J Respir Crit Care Med
; 195(5): 557-582, 2017 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128970
12.
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
Eur Respir J
; 49(3)2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28182564
13.
A randomized, seven-day study to assess the efficacy and safety of a glycopyrrolate/formoterol fumarate fixed-dose combination metered dose inhaler using novel Co-Suspension™ Delivery Technology in patients with moderate-to-very severe chronic obstructive pulmonary disease.
Respir Res
; 18(1): 8, 2017 01 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28061907
14.
Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.
Respirology
; 22(3): 575-601, 2017 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28150362
15.
Rate of Decline of FEV1 as a Biomarker of Survival?
Am J Respir Crit Care Med
; 203(6): 663-665, 2021 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33095996
16.
Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.
Am J Respir Crit Care Med
; 194(11): 1319-1336, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27589227
17.
Lung Function Abnormalities in Smokers with Ischemic Heart Disease.
Am J Respir Crit Care Med
; 194(5): 568-76, 2016 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27442601
18.
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal.
Am J Respir Crit Care Med
; 204(11): 1251-1258, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34570991
19.
Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial.
Lancet
; 385(9971): 857-66, 2015 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-25684586
20.
Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD.
Respir Res
; 17(1): 109, 2016 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27586537